QPPV.COM KNOWLEDGE ASSESSMENT

Missing Information

Test your understanding of the concepts covered by Missing Information.

Question 1 of 10Pass mark: 80%

Question 1 of 10 Which event could justify reclassification of a Missing Information item to an Important Potential Risk?
Question 2 of 10 A sponsor has identified a clinically relevant gap but concludes that obtaining reliable data is not realistically feasible. What approach is most consistent with the article?
Question 3 of 10 A medicine is expected to be used chronically, but the clinical development programme has a median treatment exposure of six months. What is the strongest reason this may represent Missing Information?
Question 4 of 10 For a rare outcome in a large real-world population, which design principle is most appropriate?
Question 5 of 10 Which cross-functional group is best suited to make a robust Missing Information classification decision?
Question 6 of 10 Which governance arrangement best reflects the article's recommended division of responsibilities?
Question 7 of 10 Who has overall oversight of the pharmacovigilance system and should ensure that Missing Information decisions are appropriately documented and managed?
Question 8 of 10 Which factor would most strongly support classifying absent data in severe renal impairment as Missing Information?
Question 9 of 10 What is the value of maintaining quantitative metrics such as exposure, person-years, enrolment and data completeness for Missing Information activities?
Question 10 of 10 Which action is generally most proportionate when a relevant knowledge gap has limited potential to change clinical use but can still be monitored through routine systems?

Select an answer to continue.

QPPV.com